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Abstract.  To investigate putative  sorting domains  in 
precursors  to polypeptide hormones,  we have con- 
structed  fusion proteins  between the amino terminus  of 
preproinsulin  (ppI) and the bacterial  cytoplasmic en- 
zyme chloramphenicol  acetyltransferase  (CAT).  Our 
aim is to identify sequences in ppI,  other than the sig- 
nal peptide,  that are necessary to mediate the intracel- 
lular  sorting and  secretion of the bacterial  enzyme. 
Here we describe the in vitro translation  of mRNAs 
encoding  two chimeric  molecules containing  71  and  38 
residues,  respectively,  of the ppI NH2 terminus  fused 
to the complete CAT sequence.  The ppI signal peptide 
and  14 residues of the B-chain were sufficient to direct 
the translocation  and  segregation  of CAT into micro- 
somal membrane vesicles.  Furthermore,  the CAT 
enzyme underwent  N-linked  glycosylation,  presumably 
at a  single cryptic site,  with an efficiency that was 
comparable to that of native glycoproteins  synthesized 
in vitro.  Partial  amino-terminal  sequencing  demon- 
strated that the downstream  sequences in the fusion 
proteins  did not alter the specificity of signal pepti- 
dase,  hence cleavage of the ppI signal peptide oc- 
cuffed at precisely the same site as in the native 
precursor.  This  is in contrast to results found in 
prokaryotic systems.  These data demonstrate  that the 
first 38 residues of ppI encode all the information 
necessary for binding  to the endoplasmic  reticulum 
membrane,  translocation,  and proteolytic (signal  se- 
quence) processing. 
I 
N recent years the process of intracellular  protein traf- 
ticking  and secretion has been described in detail for 
eukaryotic ceils (5) and some of the primary events in 
the secretory pathway have been characterized  (26).  How- 
ever, the precise molecular mechanisms that regulate intra- 
cellular sorting of secretory proteins are still poorly under- 
stood. Our laboratory is concerned with elucidating putative 
sorting  sequences  in  presecretory  proteins,  particularly 
those whose secretion is regulated in response to environ- 
mental stimuli. To this end we have been studying the biosyn- 
thesis and posttranslational  processing of precursors to the 
pancreatic  islet hormones,  insulin,  glucagon,  and somato- 
statin,  as models for secretory proteins.  Insulin  is particu- 
larly appropriate for such studies since it is one of the best 
characterized of all polypeptide hormones.  The cDNA and 
gene sequence of preproinsulins (ppI) 1 have been determined 
from  numerous  species  as  has  the  x-ray  crystallographic 
structure of the mature hormone (2, 24). In all species, ppI 
is synthesized in pancreatic  13 cells and comprises a signal 
peptide,  the  B-chain,  C-peptide,  and  A-chain.  The  signal 
1. Abbreviations  used in this paper: CAT, chloramphenicol acetyltransfer- 
ase; EndoH, endoglycosidase H; ER, endoplasmic reticulum; pI, proinsu- 
lin; ppl, preproinsulin. 
peptide is cleaved cotranslationally  (4, 20) to yield nascent 
proinsulin (pI) in which the B- and A-chains of mature insu- 
lin are joined by the C-peptide, which is flanked by two pairs 
of basic amino acids.  One function of the C-peptide is to 
facilitate the correct folding ofpI so that the disulfide bridges 
that  link the A- and  B-chains  in mature  insulin  can form 
efficiently (24).  Proteolytic cleavage of pI to insulin occurs 
at the paired basic amino acids by enzyme(s) localized in the 
secretory granules, resulting in secretion of both insulin and 
the C-peptide. Although no topogenic sequences other than 
the signal peptide have been identified in ppI, it is possible 
that the correct folding of pI might be important for efficient 
intracellular transport of the molecule through the secretory 
pathway.  Since  ppI  undergoes  only  two  posttranslational 
modifications, i.e., disulfide bridge formation and proteoly- 
sis, it represents a relatively simple peptide hormone precur- 
sor in which to investigate putative topogenic sequences. 
Using ppI as a model,  we have previously demonstrated 
(4) that there  is a  minimum  size (60-70 amino  acids)  for 
productive interaction of the nascent precursor with signal 
recognition  particle  and  the  endoplasmic  reticulum  (ER) 
membrane.  To determine  if this minimum  size might also 
constitute  the  minimum  amount  of structural  information 
necessary to facilitate translocation of any nascent proteins 
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Figure 1. Construction of ppI-CAT Fusions. (A) Generation of ppI fragments. Clone 1:413-I1 was digested with PstI, and the PstI fragment 
of 220 bp indicated by the asterisk was gel purified.  This fragment, encoding the 72 NH2-terminal amino acids of ppI, was digested with 
T4 polymerase to remove single-stranded 3' ends, then ligated  to 12-bp EcoRI linkers for subcloning into the EcoRI site of pBR322.  The 
PstI fragment (with EcoRI sticky ends) was digested with SalI, blunt-ended with the Klenow fragment of DNA polymerase I, and ligated 
to 12-bp EcoRI linkers as above. This fragment was then subcloned into the EcoRI site of pBR322  for amplification and purification.  (B) 
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techniques to construct fusion proteins between ppI and the 
bacterial enzyme chloramphenicol acetyltransferase (CAT). 
Since CAT normally resides in the bacterial cytoplasm, the 
aim of these studies is to identify and characterize putative 
sorting domains in ppI and pI that could mediate the intracel- 
lular transport and secretion of a normally nonsecretory pro- 
tein, i.e., the bacterial cytoplasmic enzyme CAT. 
As a first step towards  defining putative topogenic deter- 
minants in ppI, we have investigated the in vitro biosynthesis, 
membrane translocation, and cotranslational modifications 
of ppI-CAT fusions. Here we report that the ppI signal pep- 
tide and a portion of the B-chain can mediate the efficient 
translocation of CAT  into mammalian microsomal mem- 
brane vesicles. In addition, a  single cryptic N-linked gly- 
cosylation site present in the CAT molecule is apparently 
recognized by the microsomal membranes, such that a glyco- 
sylated form of CAT is synthesized in vitro with an efficiency 
that is comparable to native glycoproteins. 
Materials and Methods 
Materials 
Plasmid pDS5 was a gift from Dr. B. Dobberstein, European Molecular Bi- 
ology  Laboratory,  Heidelberg,  Federal  Republic  of  Germany.  Rabbit 
anti-CAT serum was a gift from Dr. D. Wong (Albert Einstein College of 
Medicine), and guinea pig anti-porcine insulin was purchased from Miles 
Laboratories.  Endoglycosidase  H was a gift from Dr. P. Atkinson (Albert 
Einstein College  of Medicine).  [3H]leucine  and  [35S]cysteine were  pur- 
chased from Amersham/Searle Corp., Arlington Heights,  IL at the highest 
available specific activity. Escherichia coli RNA polymerase  and 7mGpppA 
were purchased  from P-L Biochemicals,  Inc., Milwaukee,  WI. Restriction 
enzymes were purchased from BRL, Gaithersburg, MD or New England 
Biolabs,  Beverly, MA, and used as recommended by the manufacturers. 
Methods 
Construction  of an Islet cDNA L/brary.  A pancreatic islet cDNA library 
was  constructed from anglertish (Lophius  americanus)  polyA-containing 
mRNA exactly as described by Gubler and Hoffman (8). Bacterial transfor- 
mants were screened for ppI inserts by colony hybridization (6) using a nick- 
translated 220-bp PstI fragment of a  partial ppI cDNA clone,  pAFI-I1, 
which was isolated from a previous cDNA library (27). This clone had been 
shown to be specific  for ppI by hybrid-select translation of anglerfish 
mRNA. Several positive clones were analyzed in detail by restriction map- 
ping and by didcoxy  DNA sequencing (18); one such clone,  designated 
p413-I1, was found to contain full-length  ppI cDNA. 
Construction  ofppI-CAT Hybrid Genes. A scheme for the construction 
of the hybrid cDNAs is outlined in Fig.  1. Clone p413-I1 was digested with 
PstI,  and the 220-bp fragment, encoding the ppI signal peptide,  B-chain, 
and a portion of the C-peptide,  was purified  by polyacrylamide  gel elec- 
trophoresis.  The Pst I fragment was blunt-ended by digestion with T4 DNA 
polymerase,  and EcoRI linkers (12 bp) were added. 1 lag of this PstI/EcoRI 
fragment was digested with SalI, and the 5' overhang was filled in with the 
Klenow fragment ofDNA polymerase I and ligated to EcoRI linkers (12 bp) 
(Fig.  1 A ). Both the PstI fragment and the SalI fragment containing EcoRI 
ends were ligated into pDS5 that had been digested with EcoRI and alkaline 
phosphatase (Fig.  1 B). The resulting plasmids,  p5PI.CAT and p5SI.CAT, 
encode chimeric ppI-CAT  fusions designated ppPI.CAT  and ppSI.CAT, 
which have 313 and 280 amino acids,  respectively,  ppPI.CAT contains the 
ppI signal peptide,  B-chain, and 17 residues  of the C-chain, as well as 23 
residues  from the polylinker of pDS5 (25),  and the entire CAT sequence 
(Fig.  1 B, top). ppSI.CAT possesses the ppI signal peptide,  14 amino acids 
of the B-chain, 23 residues of the polylinker,  and the entire CAT sequence 
(Fig. 1 B, bottom). The predicted amino acid sequence encoded by the pDS5 
polylinker in both plasmids is: Arg-Asn-Ser-Arg-Gly-Ser-Val-Asp-Leu-Gln- 
Pro-Ser-Leu-Ala-Arg-Phe-Ser-Gly-Ala-Lys-Glu-Ala-Lys. 
In Vitro Transcription.  DNA from the appropriate plasmids was isolated 
by CsC1 centrifugation and was transcribed in vitro using E. coil RNA poly- 
merase and the cap analogue 7mGpppA exactly  as described by Stueber 
et al. (25). 
In Vitro Translation.  Cell-free translation of in vitro transcribed mRNA 
was performed as previously described (20) using the wheat germ cell-free 
system  containing 800 gCi/mi  [3SS]cysteine and  1 mCi/ml  [3H]leucine. 
The isolation of anglerfish islet mRNA and canine microsomal membranes 
and their use in the wheat germ system was as previously described (4, 20, 
21). Immunoprecipitation of the translation products was as described (13) 
with the following modifications:  aliquots of the translation products were 
adjusted to 2% SDS, 4 mM L-cysteine, and incubated at 42°C for 5 min, 
followed by addition of 5 vol of immunoprecipitation  buffer (13). The appro- 
priate antiserum (3 1~1 anti-CAT, 8 gl anti-insulin) was added, and the sam- 
ples incubated at 4°C overnight. Immunoprecipitates  were treated with pro- 
tein A Sepharose  and washed four times. The final pellet was resuspended 
in SDS PAGE loading buffer and incubated at 60°C for 3 min, followed by 
alkylation and analysis by SDS PAGE on 15% polyacrylamide  gels. 
Assay for Translocation  of CAT-related Polypeptides into Membrane 
Vesicles. Resistance  to posttranslational proteolysis  was used to assay for 
the segregation of nascent pI-CAT fusions into microsomal membrane vesi- 
cles.  Aliquots of the translation products synthesized  in the absence and 
presence of microsomal membranes were adjusted to 3.6 mM tetracaine and 
digested with 250 ~tg/ml each of trypsin and chymotrypsin as previously de- 
scribed (21). Afar incubation for 1 h at 0°C, the digestions were terminated 
by adjusting the samples to 2 mM PMSF and 800 U/rrd Trasylol.  Samples 
were then prepared for SDS PAGE. 
Endoglycosidase H (EndoH).  Glycosylation  of pI-CAT fusions was as- 
sayed by sensitivity to digestion with EndoH. Translation  products synthe- 
sized in the presence of microsomal membranes were adjusted to 1% SDS 
in a total volume of 18 ~tl and incubated at 95°C for 3 min. 6 ~tl of 0.1 M 
citrate phosphate buffer, pH 5.0, were added,  followed by 1 Ixl of EndoH 
(0.04 U); 1 lal of water was added to control samples.  Incubations were for 
16-20 h at 37°C;  the digestion  was terminated by incubating  the samples 
at 95°C for 3 rain followed by precipitation in 10% cold TCA-containing 
2 mM cysteine.  The TCA pellets  were  resuspended  in SDS  gel  loading 
buffer and analyzed by SDS PAGE. 
Partial NHz-terminal  Sequencing  of the Fusion Proteins. Appropriate 
bands were located by autoradiography, excised from the dried gel, and sub- 
jected to up to 40 cycles of automated Edman degradation using a spinning 
cup sequencer (model 890C;  Beckman Instruments Inc., Fullerton, CA), 
as previously described (20, 22), with the following modification.  Radiola- 
beled polypeptides  were electrophoretically  eluted as follows: the gel slices 
were rehydrated in electrophoresis tank buffer (0.05 M Tris, 0.38 M glycine) 
containing 2% SDS; the rehydrated  gel pieces were placed in an electro- 
phoretic concentrator elution chamber (model  1750; Isco,  Inc., Lincoln, 
NE) containing 0.01 M Tris, 0.077 M glycine, and 0.1% SDS; the apparatus 
was filled with electrophoresis tank buffer containing 0.1% SDS. Electroelu- 
tion was performed at 1 W (constant power) overnight.  The eluate (200 ~tl) 
was diluted with an equal volume of sterile water, dialyzed  briefly against 
water, and loaded into the spinning cup of the sequencer containing 4 mg 
polybrene and 1 mg of myoglohin  (27). 
Generation of p5PI.CAT and p5SI.CAT, pDS5 was digested with EcoRI and dephosphorylated with calf intestinal phosphatase (CIP). The 
vector was then ligated with either the PstI fragment or the SalI fragment, both containing EcoRI cohesive ends, and the ligation reaction 
used to transform E.  coli strain MC1000.  Positive clones were identified by colony hybridization using the nick-translated PstI fragment 
of 1M13-I1 as a probe. Those clones containing either the Pstl or Sail fragment were amplified and plasmid DNA was prepared. The plasmids 
p5PI.CAT and p5SI,CAT were subjected to coupled transcription and translation, yielding the two fusion proteins ppPI.CAT and ppSI.CAT. 
bla, ~lactamase gene; SP, signal peptide; B, B-chain; C, C-peptide; P, PstI; S, Sail. Hatched bar in p413-I1  represents ppI coding region; 
open bar represents ppI coding region in the fragments; filled-in region represents EcoRI linkers.  L,  polylinker region of pDS5;  Pro, 
coliphage promoter; RBS, prokaryotic ribosome binding site; t~, transcription terminator of the rnnB operon in E.  coli;  and E,  EcoRI. 
Arrowhead indicates the signal cleavage site; triangle indicates the cryptic site for N-linked glycosylation in the CAT protein; double aster- 
isks indicate the paired basic cleavage site Lys-Arg between the B-chain and the C-peptide of ppPI.CAT. 
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Construction of  ppI-CAT Fusions 
The construction of the two ppI-CAT fusion proteins is di- 
agrammed in Fig.  I.  Plasmid p5PI.CAT encodes a  hybrid 
protein of 313 amino acids comprising the anglerfish ppI sig- 
nal peptide  (24 residues),  the complete B-chain (30 resi- 
dues), the first 17 residues of the connecting peptide (C-pep- 
tide), a 23 amino acid peptide encoded by the linker region 
of pDS5 (see Materials and Methods), and the complete CAT 
sequence (219 amino acids). Plasmid p5SI.CAT encodes a 
hybrid protein of 280 amino acids possessing the complete 
ppI signal peptide, the first 14 residues of  the insulin B-chain, 
the same 23 residue polypeptide encoded by the linker region 
of pDS5, and the complete CAT sequence. In addition, both 
plasmids  encode a  cryptic site for N-linked glycosylation 
(Asn-Gln-Thr) present at residues 34 through 36 of the native 
CAT  molecule;  this  sequence  starts  at  position  128  in 
ppPI.CAT and at residue 95 in ppSI.CAT.  The structure of 
these plasmids was confirmed by detailed restriction digests, 
DNA sequencing, and partial amino acid sequence analysis 
(Fig.  5) of the translation products. 
In Vitro Biosynthesis of  Fusion Proteins 
Initially we determined if the NH2-terminus of ppI could di- 
rect the translocation of CAT into mammalian microsomal 
membranes.  To this  end,  RNA  transcribed  in  vitro from 
plasmids  p5PI.CAT  and  p5SI.CAT  was  translated  in  the 
wheat germ cell-free system in the absence and presence of 
microsomal membranes (Fig.  2). In the absence of micro- 
somes the translation products encoded by both plasmids 
p5PI.CAT and p5SI.CAT were significantly larger than an- 
glerfish ppI or native CAT (Fig. 2 A, lanes 1, 3, 5, and  7) 
and were of the expected size for the two predicted fusion 
proteins,  i.e.,  Mr 31,000  for ppPI.CAT and Mr 28,000  for 
ppSI.CAT.  To confirm that these products were fusion pro- 
teins between ppI and CAT, the translation products were 
treated with antibodies directed against porcine insulin or 
CAT (Fig.  2,  B and  C,  lanes 1 and 3,  respectively). Both 
ppPI.CAT  and  ppSI.CAT  were  immunoprecipitated  with 
anti-insulin and anti-CAT antibodies, indicating they had the 
predicted antigenic determinants. Some cross-reactivity be- 
tween the anti-insulin serum and the CAT translation prod- 
ucts generated from transcription of the parent vector pDS5 
was noted (Fig. 2 B, lanes 5 and 6).  This cross-reactivity, 
which was variable with different batches of antisera, is most 
likely due to the presence of trace levels of endogenous CAT 
antigen, synthesized by B. subtilis,  a component of Freund's 
complete adjuvant used for the initial immunization of the 
animals.  Consequently, the final serum may contain a low 
level of CAT antibodies in addition to anti-insulin antibodies. 
Both ppI and pI (Fig. 2 B, lanes 7and 8) were efficiently  rec- 
ognized by the anti-insulin antibody, while, as expected, the 
anti-CAT antibodies showed no cross-reactivity with ppI or 
pI (Fig. 2  C, lanes  7 and 8). 
In the presence of microsomal membranes,  nascent ppI 
was cotranslationally cleaved to pI (Fig. 2 B, lanes 7 and 8; 
reference 20).  Surprisingly, the translation products from 
ppPI.CAT and ppSI.CAT mRNA synthesized in the presence 
of membranes were processed to two forms. One form was 
of slightly faster mobility (Fig. 2, A, B, and C; lanes 2 and 
Figure 2. Characterization ofppI-CAT fusions. Plasmids p5PI.CAT, p5SI.CAT,  and pDS5 were  transcribed in vitro (25) and the RNA trans- 
lated in the wheat germ system in the absence (-) or presence (+) of 2.5 A260/ml microsomal membranes (Mb). Total islet mRNA (lanes 
7 and 8) was translated under identical conditions (see Materials and Methods). After translation, aliquots were either analyzed directly 
by electrophoresis on 15% acrylamide SDS gels (A) or treated with anti-insulin antibodies (B) or anti-CAT antiserum (C) followed by 
SDS PAGE. The samples in lanes 1-8 are identical in each panel. Translation of products of p5PI.CAT, lanes 1 and 2; lane 1, ppPI.CAT, 
arrowhead; lane 2, pPI.CAT, upward pointing arrowhead indicates fusion protein lacking its signal peptide, downward pointing arrow indi- 
cates putative glycosylated form of fusion protein. Translation of products of p5SI.CAT, lanes 3 and 4; lane 3, ppSI.CAT, arrowhead; lane 
4, pSI.CAT, upward arrow indicates fusion protein lacking its signal peptide, downward pointing arrow indicates glycosylated  form of fusion 
protein. Translation products of pDS5-CAT, lanes 5 and 6. Translation products of anglerfish islet mRNA, lanes 7 and 8; dot (lane 7) 
ppI; asterisk (lane 8), pI (20). 
The Journal of Cell Biology,  Volume 103, 1986  2266 Figure 3. Segregation of ppI-CAT fusions. Plasmids p5PI.CAT and p5SI.CAT were transcribed  in vitro and the RNA translated in the ab- 
sence (-) and presence  (+) of 3 A26o/ml microsomal membranes.  After translation,  aliquots were adjusted to 10 mM CaCI2, 3 mM tetra- 
caine and treated with either protease (T/C, 250 ~tg/mi each of trypsin and chymotrypsin)  or with protease in the presence  of 1% Triton 
X-100 (TX).  Samples were incubated for 1 h at 4°C and then treated with 2 mM PMSF and prepared for SDS PAGE. (A) Products  of 
p5PI.CAT. (B) Products of p5SI.CAT. Lane 1, products synthesized in the absence of membranes; lane 2, products synthesized in the pres- 
ence of  membranes; lanes 3 and 4, as lanes I and 2 but treated with trypsin and chymotrypsin; lanes 5 and 6, as 3 and 4 except that proteolysis 
was performed in the presence of 1% Triton X-100. Large arrowhead (left of lanes A 1 and B 1 ), ppPI.CAT and ppSI.CAT, respectively. 
Lanes 2 and 4, downward and upward pointing arrowheads,  protease resistant forms of fusion protein; lane 2, asterisks, residual ppPI.CAT 
and ppSI.CAT, respectively. 
4, lower arrow) and was presumably the fusion protein minus 
its signal peptide. The second form of processed fusion pro- 
tein migrated more slowly than the precursor (Fig. 2, A, B, 
and C; lanes 2  and 4, downward pointing arrows).  No such 
processed forms of CAT were seen when  native CAT,  en- 
coded by pDS5, was synthesized in the absence or presence 
of microsomal membranes (Fig. 2, A and C, lanes 5 and 6). 
The translation products from pDS5 appeared to migrate as 
a doublet on SDS gels; the reason for this is unclear.  How- 
ever,  the  appearance of this doublet was unaffected by the 
presence or absence of microsomal membranes, indicating 
that it is not due to the incorporation of CAT into microsomes. 
Segregation of the Fusion Proteins 
To further analyze the nature of the fusion proteins synthe- 
sized in the presence of microsomal membranes, the trans- 
lation  products  were  assayed  for  translocation  into  the 
microsomal vesicles by determination of their sensitivity to 
protease digestion (Fig. 3). Aliquots of the translation prod- 
Eskridge and Shields Preproinsulin-Bacterial Fusion Proteins  2267 Figure 4. N-linked glycosylation of ppI-CAT fusions. Plasmids p5PI.CAT and p5SI.CAT were transcribed  and translated as outlined in 
Figs. 2 and 3. At the end of the incubation, samples were made 1% SDS and incubated for 3 rain at 95°C. Samples were then adjusted 
to 25 mM citrate, pH 5.0, and digested with 0.04 U EndoH for 16 h at 37°C. Lane 1, ppPI.CAT synthesized in the absence of membranes; 
lane 2, pPI.CAT synthesized in the presence of microsomal membranes; lane 3, as lane 2 but treated with EndoH; lane 4, as lane 3, not 
treated with EndoH; lane 5, ppSI.CAT synthesized in the absence of membranes; lane 6, pSI.CAT synthesized in presence of membranes; 
lane 7, as lane 6 but treated with EndoH; lane 8, as lane 7 but not treated with EndoH. (Downward  pointing arrows) glycosylated form 
of fusion protein.  (Upward  pointing arrows) nonglycosylated forms of fusion protein lacking its signal peptide. 
ucts were treated with a mixture of trypsin and chymotrypsin 
in the absence and presence of the detergent Triton X-100. 
Fusion proteins ppPI.CAT and ppSI,CAT synthesized in the 
absence of membranes were completely sensitive to protease 
treatment (Fig. 3, A and B, lane 3) indicating that these pro- 
teins were not intrinsically protease-resistant.  In contrast, 
the  two putative processed forms of each fusion protein, 
pPI.CAT and pSI.CAT, synthesized in the presence of mem- 
branes, were protease-resistant (Fig. 3, A and B, lane 4), in- 
dicating that they were shielded by the membrane bilayer. 
This was confirmed when proteolysis was performed in the 
presence of Triton X-100. In this ease, these products were 
completely digested (lane 6).  These data indicate that the 
two processed forms of each fusion protein were completely 
segregated into the cisternae of the microsomal vesicles. 
Glycosylation  of  ppI-CAT Fusions 
The appearance of a slower migrating form of processed fu- 
sion proteins,  resulting  from synthesis  in  the presence of 
microsomal membranes, was similar to that seen for numer- 
ous glycoproteins synthesized in vitro (e.g., VSV-G protein 
(13)). We therefore hypothesized that the molecules of slower 
electrophoretic mobility were glycosylated forms of the fu- 
sion proteins, whereas those migrating faster than ppPI.CAT 
or ppSI.CAT corresponded to processed molecules in which 
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glycosylated.  Although neither  ppl nor CAT are normally 
glycosylated in vivo, CAT does encode a cryptic recognition 
site  for  N-linked  glycosylation:  Asn-Gly-Thr,  at  residues 
34-36 of the native molecule. This site appears at residues 
128-130 in ppPI.CAT and residue 95-97 in ppSI.CAT. Since 
ppI sequences in both fusions mediated translocation of CAT 
into microsomal vesicles, it is possible that this site was rec- 
ognized  by the  glycosylation enzymes  in  the  microsomal 
membranes. The prediction that the higher molecular weight 
forms of the fusion proteins (Fig. 4, lanes 2 and 6) were gly- 
coproteins was tested by subjecting the translation products 
to treatment with EndoH. Since high mannose core oligosac- 
charides  added to nascent glycoproteins in the ER can be 
cleaved by EndoH digestion, the glycosylated fusion proteins 
should be sensitive to this enzyme. EndoH digestion was per- 
formed on translation  products  generated  from p5PI.CAT 
and p5SI.CAT  synthesized in  the presence  of microsomal 
membranes,  and the samples were analyzed by SDS PAGE 
(Fig.  4).  In  the presence  of EndoH  (lanes  3  and  7),  the 
slower migrating species of both fusions (upper arrows) was 
quantitatively  converted to a form which then co-migrated 
with the faster migrating species observed in the presence of 
membranes (lanes 2 and 6, lower arrows); i.e., after removal 
of the single N-linked carbohydrate chain, the resulting prod- 
uct co-migrated with a protein that  represented the fusion 
protein minus its putative signal peptide. 
During the course of these experiments, we noted that both 
proteolytic processing of the signal peptide and glycosyla- 
tion of pPI.CAT and pSI.CAT were particularly efficient, as 
judged by autoradiographic intensity (Figs. 3 and 4). To quan- 
titate the relative efficiencies of proteolytic processing and 
glycosylation, gel bands corresponding to both the glycosyl- 
ated and unglycosylated forms of each fusion protein were 
excised from the dried gels, solubilized, and their radioactiv- 
ity determined directly (Table I). In several experiments in 
which 43 % of nascent ppI was processed to pI,  the fusion 
proteins were processed with an efficiency of 65-70 %. Simi- 
larly,  glycosylation of the fusion proteins  was particularly 
efficient,  ,'~45%  of pPI.CAT  and  68%  of pSI.CAT  were 
glycosylated. These values are comparable to the efficiency 
of glycosylation of native glycoproteins synthesized under 
these conditions (data not shown). 
Table I. Efficiency  of  Processing and Glycosylation 
of ppI-CAT Fusions 
Protein  Processing*  Glycosylation~: 
%  % 
ppI  43.4  (5)  NA 
ppPI.CAT  66.5  (3)  45.6  (3) 
ppSI.CAT  69.6  (3)  68.0  (3) 
The appropriate  polypeptides were excised from the dried gel (Fig. 4) solubi- 
lized in 30% H20: (4), and the radioactivity  determined by liquid scintillation 
counting.  Numbers in parenthesis represent total number of experiments. NA, 
not applicable. 
* Processing  cpm in processed forms (upper and lower)  x  100 
(cpm in precursor +  cpm in processed forms) 
~t Glycosylation  cpm in upper processed form  x  100 
(cpm in lower +  cpm in upper forms) 
Partial NHrterminal Sequencing of the Fusion Proteins 
The antibody precipitation data (Fig. 2) indicated that both 
ppPI.CAT and ppSI.CAT were fusion proteins between ppI 
and  CAT. However,  since  the  anti-insulin  antibodies  had 
some cross-reactivity with authentic CAT, it was necessary 
to unequivocally demonstrate that the fusion proteins were 
indeed  those predicted.  We therefore  subjected ppPI.CAT 
and ppSI.CAT to partial NH2-terminal sequencing. Previous 
studies (9, 22) had shown that leucine residues were present 
at positions 3, 5, 10, 12, 13, and 14 of the signal peptide, and 
leucine and cysteine were present  at positions  30 and  31, 
respectively, of ppI (corresponding to residues 7 and 8 of the 
insulin  B-chain).  Consequently,  ppPI.CAT  and  ppSI.CAT 
were  synthesized  in  the  presence  of  [3H]leucine  and 
[35S]cysteine  and  electrophoresed  on  15%  polyacrylamide 
gels. The appropriate bands were localized by autoradiogra- 
phy,  the proteins  eluted and subjected to microsequencing 
(Fig. 5, A and B). Leucine and cysteine residues were found 
at the expected positions; these results not only confirm the 
accuracy of the antibody data but conclusively demonstrate 
that the fusion proteins contained the ppI signal peptide. 
It is possible that foreign sequences downstream from the 
signal  peptide might  influence the site of signal peptidase 
cleavage (1). Therefore it was of interest to determine if both 
of the precursor fusion proteins  were correctly cleaved by 
signal peptidase, particularly since ppSI.CAT contained only 
fourteen residues of the insulin B-chain.  The polypeptides 
corresponding  to  the  glycosylated  forms  of pPI.CAT  and 
pSI.CAT  (Fig.  4,  upper band)  synthesized in the presence 
of [3H]leucine,  [35S]cysteine  and  microsomal  membranes, 
were eluted from gels and also subjected to microsequenc- 
ing,  (Fig.  5,  C and D).  Previously, it had been shown that 
cleavage of the signal peptide occurred between residues 24 
and 25 of anglerfish  ppI  (20).  Consequently,  if ppPI.CAT 
were accurately cleaved by signal peptidase, leucine residues 
would be present at positions 7, 12,  16, and 18, and cysteine 
at residues 8 and 20. The data (Fig. 5 C) show that this was 
the case and is consistent with correct cleavage of the signal 
peptide.  The sequence data from the glycosylated form of 
pSI.CAT  (Fig.  5 D) also demonstrated leucine residues at 
positions 7 and  12 and a  cysteine residue at position 8.  In 
addition, novel leucine residues were found at positions 23 
and 27. These leucines correspond to those predicted from 
DNA sequencing of the linker region from pDS5. Most im- 
portantly,  the  data  demonstrate  that  the  signal  peptide  of 
ppSI.CAT was also cleaved at the same position as in the na- 
tive precursor, even though the fusion protein contains only 
fourteen residues of the insulin B-chain.  Thus,  our results 
demonstrate that the downstream sequences do not influence 
the site of cleavage of the ppI signal peptide. 
Discussion 
Most  small  polypeptide  hormones  (less than  ~50  amino 
acids) are synthesized as part of a larger precursor molecule; 
in some cases the precursor may also be a polyprotein con- 
mining repeating units of the same peptide or several differ- 
ent hormones (3). We are attempting to decode putative sort- 
ing  information  that  may be present  in  the proregions  of 
a  variety  of diverse peptide  hormone  precursors.  To this 
end, we have synthesized chimeric genes encoding variable 
amounts of the NH2-terminus of ppI fused to CAT,  a bac- 
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Figure 5. Partial NH2-terminal sequence of ppI-CAT and pI-CAT fusions. Plasmids p5PI.CAT and p5SI.CAT were transcribed and trans- 
lated  in the wheat  germ  system containing both  [3sS]cysteine and  [3H]leucine (1  mCi/ml  of each)  in the absence and presence  of 
microsomal membranes and the translation products resolved by SDS PAGE. After autoradiography, bands corresponding to ppPI.CAT 
(A), ppSI.CAT (B), the glycosylated forms of  pPI.CAT ( C ), and pSI.CAT (D) were excised and the polypeptides electrophoretically eluted. 
The eluted samples were applied to a sequencer (model 890C; Beckman Instruments, Inc.) and subjected to automated Edman degradation. 
(Solid line) [3H]leucine; (dashed line) [3SS]cysteine;  (asterisks) known or predicted leucine and cysteine residues that were confirmed in 
this analysis; (arrowhead; A, C, and D) site of signal peptide cleavage (20). (Heavy black line; D) indicates novel amino acids encoded 
by the linker region of pDS5 (see Materials and Methods). Single letter code: A, Ala; C, Cys; D, Asp; F, Phe; G, Gly; H, His; L, Leu; 
M, Met; N, Ash; P, Pro; Q, Glu; R, Arg; S, Ser; V, Val; W, Trp; Y, Tyr. 
terial cytoplasmic enzyme. The rationale for these experi- 
ments is to identify sequence information within ppI that 
could mediate the sequestration of CAT molecules into the 
secretory pathway, perhaps ultimately leading to its secre- 
tion. Since we had shown (4) that ppI interacts with the ER 
when  about half the  molecule has  been  synthesized,  we 
postulated that sorting information in the first 60 residues 
of ppI,  which  includes  the  NH2-terminal  signal  peptide, 
should be  sufficient to effect translocation of any  protein 
across the ER membrane. 
To test this hypothesis directly, we have constructed two 
fusion proteins. One, ppPI.CAT, contained the first 71 resi- 
dues ofppI, including the complete signal peptide and B-chain 
and part of the C-peptide fused to CAT. The other fusion pro- 
tein, ppSI.CAT,  possessed only 38 amino acids of ppI (the 
signal peptide plus 14 residues of the B-chain) fused to CAT. 
It is noteworthy that the polylinker sequence, present in both 
fusion proteins, contained seven charged residues;  conse- 
quently, it might be expected that these could interfere with 
membrane translocation. However, both fusions, ppPI.CAT 
and  ppSI.CAT,  were  capable  of targeting  to  microsomal 
membranes,  as  well  as  translocating  through  the  lipid 
bilayer, suggesting that local charge effects per se may not 
necessarily inhibit translocation. Since the relative efficien- 
cies of glycosylation and signal peptide cleavage were virtu- 
ally identical in the two constructions (Table I), it is possible 
that ppSI.CAT, as well as ppPI.CAT, contains all the neces- 
sary structural domains to effect  efficient translocation of  for- 
eign proteins into the lumen of  the ER. This result was some- 
what surprising, since a construction of 45 residues, which 
encodes only the first 38 amino acids of pp! and no CAT se- 
quences, bound poorly to microsomal membranes and was 
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manuscript submitted for publication). These results suggest 
that, providing the 38 NH2-terminal residues of ppI can as- 
sume an appropriate conformation, by virtue of being fused 
to foreign sequences, in this case CAT, targeting and translo- 
cation domains in the nascent precursor can be recognized 
by the ER translocation machinery. 
Our data contrast with results seen from an analogous con- 
struction in prokaryotes. When the signal peptide and the 
first 15 amino acids of LamB were fused to the LacZ gene 
and expressed in E.  coli,  ~galactosidase remained in the 
cytoplasm, suggesting that additional LamB sequences are 
necessary to direct insertion of the hybrid protein into the in- 
ner membrane (15). Similarly, when the 13-1actamase signal 
peptide was fused to chicken triosephosphate isomerase (11) 
only 30% of the fusion protein was targeted to the membrane 
in vivo; no signal peptide cleavage or translocation across the 
membrane was observed. At present we do not know if the 
insulin signal sequence alone is sufficient to mediate translo- 
cation of CAT  into microsomal vesicles of if the fourteen 
residues of the B-chain are also required; these experiments 
are currently in progress. 
It is noteworthy that the downstream sequences in both fu- 
sion proteins had no influence on the specificity of cleavage 
by signal peptidase. This was particularly striking in the case 
of ppSI.CAT,  which contained only 14 amino acids of the 
B-chain fused to 242 foreign residues. Nevertheless, cleav- 
age of the ppI signal peptide occurred at precisely the same 
site as in the native precursor, i.e., between Ala24 and Va125; 
this was also the case for the ppPI.CAT fusion. These results 
contrast with recent data on the signal peptide cleavage of 
Staphylococcus aureus protein A (1). In this case, when an 
internal IgG-binding fragment of protein A was inserted im- 
mediately adjacent to the signal sequence (replacing the nor- 
mal sequence), incorrect cleavage of the signal peptide was 
observed and transport into the periplasm was significantly 
less efficient than for wild-type protein A (1). These data sug- 
gest that in prokaryotic cells, at least gram-positive bacteria, 
the structure of the polypeptide chain distal to the site of 
signal cleavage may affect proteolytic processing by signal 
peptidase. 
Several experiments have demonstrated that prokaryotic 
signal sequences, e.g., E. coli 13-1actamase, can be efficiently 
recognized by the eukaryotic translocation apparatus, such 
that proteolytically processed 13-1actamase was sequestered 
into mammalian microsomal membranes in vitro (12, 16). 
Lingappa et al. (14) also showed that the signal peptide and 
the first five amino acids of 13-1actamase were sufficient to 
effect translocation of normally cytoplasmic globin chains 
into the lumen of microsomal membranes.  In contrast to 
studies on prokaryotic cells (15), these results indicated that 
relatively little structural information other than the signal 
sequence may be needed to effect translocation of a protein 
across the ER membrane. Indeed, very recent experiments 
(17) suggest that a precise fusion of the 13-1actamase signal 
peptide to appropriately engineered ct-globin chains is suf- 
ficient to mediate translocation into the ER vesicles.  Our 
results demonstrate that a eukaryotic signal sequence medi- 
ates translocation of a prokaryotic cytoplasmic protein across 
mammalian membranes. As such, this should enable us to 
distinguish between topogenic sequences sufficient for trans- 
location into the  ER  lumen from those putative domains 
needed to  mediate distal sorting events in the  eukaryotic 
secretory pathway. 
Two recent reports have also demonstrated cryptic glyco- 
sylation  of  normally  nonglycosylated proteins  (19, 23). 
Spiess  and  Lodish (23)  showed that fusion of the mem- 
brane-anchor domain of the asialoglycoprotein receptor to 
rat tz-tubulin was sufficient to mediate translocation and gly- 
cosylation of normally cytoplasmic tubulin by microsomal 
membranes in vitro. Sharma et al.  (19) constructed a chi- 
meric gene comprising the influenza virus hemagglutinin 
signal peptide and SV40 large T antigen. Expression of this 
gene in 3T3  cells resulted in T  antigen being exclusively 
localized to the ER, where both signal peptide cleavage and 
core oligosaccharide addition occurred. However, T antigen 
remained in the ER and was  not transported through the 
secretory pathway. In this context, the ppI-CAT fusions de- 
scribed here, as well as several under construction, offer an 
excellent experimental  system in which to  investigate the 
function of the pI B-chain and C-peptides,  as well as N- 
linked glycosylation, on the secretion of the CAT enzyme 
from several  different cell types. In particular it will be of 
interest to determine if glycosylation  plays a role in either the 
translocation of CAT molecules from the ER to the Golgi, 
c.f. yeast proalpha factor (10), or in post-Golgi sorting events 
(7). These experiments are currently in progress. 
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